# Terlipressin

## Glypressin inj 0.1mg/mL, 8.5mL

| TAH Drug Code      | [IGLYP8](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IGLYP8                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Bleeding oesophageal varices, and hepatorenal syndrome (HRS) Type 1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | [Bleeding oesophageal varices] Initial: 2 ampoules IV Q4H, maintained until bleeding has been controlled but up to a maximum of 48 hours. Body weight <50kg : 1 ampoule IV Q4H; maintenance dosage (if necessary), 1 ampoule IV Q4H for a maximum of 3 days. Duration of treatment must not exceed 5 days. [Type 1 hepatorenal syndrome] 3-4 ampoules IV Q24H, divided as 3 or 4 administrations. In the absence of any reduction of the serum creatinine after 3 days of treatment, cessation of treatment is advised. In the other cases, treatment is to be pursued until the obtaining either of a serum creatinine < 130 Î¼mol/litre or of a drop of at least 30 % in the serum creatinine with respect to the value measured at the time of diagnosis of hepatorenal syndrome. The standard average duration of treatment is 10 days. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Pregnancy. Hypersensitivity to terlipressin or to any of the excipients. In patients with septic shock with a low cardiac output terlipressin should not be used. Contraindicated in patients with current or recent (within the last 3 months) ischaemic cardiovascular disease.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Adverse Effects    | (1-10%) Paleness, hypertension, abdominal pain, nausea, and diarrhea. Hyponatremia, ischemia, bradycardia, respiratory failure, and Torsade de pointes.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| More Info          | [UpToDate](https://www.uptodate.com/contents/terlipressin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

